Table 8 Effects of dietary supplementation with ATC during pregnancy and lactation on the antioxidant performance of Ewes

CAT(umol/mL)

90 d

114.68

121.78

6.02

0.580

120 d

80.84

94.21

7.73

0.413

145 d

82.69

89.05

6.09

0.625

1 d

63.50

75.69

4.80

0.219

30 d

83.17

108.08

6.74

0.060

45 d

97.61

105.43

4.46

0.406

GSH-Px(U/mL)

90 d

214.69

242.59

26.31

0.620

120 d

211.56

236.97

13.64

0.377

145 d

190.35

213.88

23.92

0.646

1 d

123.91

177.04

16.96

0.121

30 d

160.76

187.99

24.10

0.597

45 d

176.04

209.43

22.88

0.492

MDA(nmol/mL)

90 d

2.46

2.08

0.19

0.339

120 d

2.42

2.53

0.14

0.698

145 d

2.66

2.47

0.09

0.315

1 d

3.65

3.39

0.39

0.756

30 d

2.89

2.70

0.10

0.344

45 d

2.46

2.27

0.10

0.377

SOD(U/mL)

90 d

142.35

147.51

6.34

0.703

120 d

111.99

125.22

4.85

0.184

145 d

100.75^b

111.66^a

2.08

0.002

1 d

93.24

98.59

6.22

0.688

30 d

131.15

140.12

6.70

0.529

45 d

134.42

142.97

6.53

0.539

T-AOC(U/mL)

90 d

9.12

10.13

1.37

0.732

120 d

8.36

8.97

0.67

0.672

145 d

8.28

8.36

0.61

0.951

1 d

6.50

7.43

0.40

0.259

30 d

7.47

8.10

0.36

0.410

45 d

9.51

10.12

0.56

0.607